WCBA
GMED icon

Weaver C. Barksdale & Associates’s Globus Medical GMED Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$4K Sell
88
-14
-14% -$490 ﹤0.01% 394
2017
Q3 		$3K Buy
102
+9
+10% +$275 ﹤0.01% 417
2017
Q2 		$3K Sell
93
-15
-14% -$471 ﹤0.01% 432
2017
Q1 		$3K Sell
108
-43
-28% -$1.17K ﹤0.01% 442
2016
Q4 		$4K Buy
+151
New +$3.43K 0.01% 406

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Weaver C. Barksdale & Associates's GMED Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Globus Medical (GMED) stake by 14% in Q4 2017, selling an estimated $490 and leaving 88 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #394.

Weaver C. Barksdale & Associates first reported a position in GMED in Q4 2016 and has held it in 5 quarters since. 263 funds tracked by Wall St. Rank hold GMED as of Q4 2017.

  • Weaver C. Barksdale & Associates held 88 shares of Globus Medical worth $4K as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 14 Globus Medical shares in Q4 2017, an estimated $490.
  • Globus Medical made up ﹤0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #394 holding.
  • Weaver C. Barksdale & Associates first reported a position in Globus Medical in Q4 2016 and has held it in 5 quarters since.
  • 263 funds tracked by Wall St. Rank held Globus Medical as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.